🇺🇸 FDA
Patent

US 8101159

In vivo methods of identifying compounds which target suppressed cancer cells

granted A61KA61K31/136A61K31/165

Quick answer

US patent 8101159 (In vivo methods of identifying compounds which target suppressed cancer cells) held by The Board of Regents of the University of Oklahoma expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/136, A61K31/165, A61K31/215, A61K31/396